- Home
- OFLX vs RCKT Comparison
OFLX vs RCKT Comparison
Compare OFLX & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- RCKT
- Stock Information
- Founded
- OFLX 1975
- RCKT 1999
- Country
- OFLX United States
- RCKT United States
- Employees
- OFLX N/A
- RCKT N/A
- Industry
- OFLX Industrial Specialties
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- OFLX Industrials
- RCKT Health Care
- Exchange
- OFLX Nasdaq
- RCKT Nasdaq
- Market Cap
- OFLX 366.4M
- RCKT 328.6M
- IPO Year
- OFLX 2005
- RCKT N/A
- Fundamental
- Price
- OFLX $35.30
- RCKT $3.28
- Analyst Decision
- OFLX
- RCKT Buy
- Analyst Count
- OFLX 0
- RCKT 13
- Target Price
- OFLX N/A
- RCKT $12.96
- AVG Volume (30 Days)
- OFLX 22.3K
- RCKT 6.0M
- Earning Date
- OFLX 10-29-2025
- RCKT 08-07-2025
- Dividend Yield
- OFLX 3.85%
- RCKT N/A
- EPS Growth
- OFLX N/A
- RCKT N/A
- EPS
- OFLX 1.69
- RCKT N/A
- Revenue
- OFLX $100,700,000.00
- RCKT N/A
- Revenue This Year
- OFLX N/A
- RCKT N/A
- Revenue Next Year
- OFLX N/A
- RCKT $108.43
- P/E Ratio
- OFLX $20.93
- RCKT N/A
- Revenue Growth
- OFLX N/A
- RCKT N/A
- 52 Week Low
- OFLX $28.12
- RCKT $2.19
- 52 Week High
- OFLX $57.81
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- OFLX 57.66
- RCKT 51.17
- Support Level
- OFLX $34.25
- RCKT $2.88
- Resistance Level
- OFLX $37.50
- RCKT $3.74
- Average True Range (ATR)
- OFLX 1.08
- RCKT 0.27
- MACD
- OFLX 0.26
- RCKT 0.02
- Stochastic Oscillator
- OFLX 54.73
- RCKT 35.43
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.